Share this post
The Drug Delivery to the Lungs Conference (DDL) 2023 is in its 34th year and attracts more than 1,000 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by over 100 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event.
- Transition to renewable materials: environmental impact assessment of renewable polymers for conceptual multidose dry powder inhaler
Author: Charlie Dean
Head of Sustainable Medical Technology
Charlie is a Principal Mechanical Engineer at Cambridge Consultants with expertise in mechanical design and design for manufacture of pharmaceutical drug delivery devices.
150 Morrison St
Edinburgh EH3 8EE